Renewed calls for a federal ban on prescription drug advertising to consumers needs to be squashed immediately, the Association of National Advertisers (ANA) says. Read More »

US Oncology Research announced recently that it has found and recruited its 2,000th patient to take part in a Phase I clinical trial through its Translational Oncology Program (TOP). Read More »

Upsher-Smith Laboratories Inc. and the National Alliance of State Pharmacy Associations (NASPA) have partnered to honor 43 pharmacists from across the United States with the 2015 NASPA Excellence in Innovation Award. Read More »

Eisai Co. and Sysmex Corp. made a joint announcement this week declaring that the two companies have agreed on a non-exclusive partnership to develop new diagnostics for the field of dementia. Read More »

Sandoz, a company owned by Novartis, announced last week that it has procured the rights to develop and commercialize PF_06438179 (infliximab) from Pfizer. Read More »

Chattem Inc., a subsidiary of Sanofi, announced last week that its product, ACT Advanced Care Mouthwash, has been named the recipient of the 2016 Product of the Year award. Read More »

The National Association of Chain Drug Stores (NACDS) is pleased with the momentum the proposed bill to combat prescription drug abuse, which cleared the U.S. Senate Judiciary Committee this week, is gaining. Read More »

AstraZeneca announced this week that it, along with its worldwide biologics research and development subsidiary, MedImmune, have entered into an agreement to partner with the University of Michigan and Eli Lilly to develop new therapeutic drugs to treat chronic kidney disease (CKD). Read More »

Sandoz announced this week that the Marketing Authorization Application (MAA) for its biosimilar to Amgen’s EU-licensed Neulasta (pegfilgrastim) has been accepted by the European Medicines Agency (EMA). Read More »

Daiichi Sankyo Co. Ltd. this week announced that it will close Daiichi Sankyo Development Limited (DSD), its subsidiary in England. Read More »

Allergan announced this week that its CEO and President, Brent Saunders, will be the keynote speaker in a fireside chat session at the RBC Capital Markets Healthcare Conference. Read More »

Accordant, a CVS Health affiliate, made an announcement this week revealing that it has been awarded Case Management Accreditation from the NCQA. Read More »

Sermonix Pharmaceuticals announced this week that two presentations will be given by experts in sexual medicine on its new medication, lasofoxifene, at the annual International Society for the Study of Women’s Sexual Health (ISSWSH) on Feb. 26 and 27 in Charleston, South Carolina. Read More »

SinfoniaRx revealed last week that it is has expanded its medication therapy management (MTM) technology to support the United States’ growing Hispanic population, which has climbed to more than 57 million people. Read More »

Verseon Corp. announced this week that it plans on unveiling new pre-clinical results in the form of a poster that will feature brand-new data for oral anticoagulant drug candidates currently in development. Read More »

AstraZeneca announced last week that TAGRISSO has been granted conditional marketing authorization by the European Commission (EC). Read More »

The American Pharmacists Association (APhA) has responded to the outbreak of the Zika virus in the Americas by providing a page for information on the virus on its website. Read More »

Medicine Shoppe International announced this week, along with the Center for Pharmacy Practice Accreditation (CPPA), that its location in Benson, Arizona has been named a community pharmacy accreditation recipient. Read More »

Pfizer Inc. has commended the United States Food and Drug Administration (FDA) Arthritis Advisory Committee for its recommendation to approve the biosimilar infliximab (CT-P13) this week. Read More »

At Congress’ first oversight hearing since the enactment of the Biologics Price Competition and Innovation Act (BPCIA) held last week, Chip Davis, president and CEO of Generic Pharmaceutical Association (GPhA), called for safe and effective biosimilars. Read More »